Contribution of antibody and T cell-specific responses to the progression of 139A-scrapie in C57BL/6 mice immunized with prion protein peptides

Journal of Immunology

Volumn 181, Issue 1, 2008, Pages 768-775

  Sacquin, Antoine ^a,b   Bergot, Anne Sophie ^c   Aucouturier, Pierre ^a,b   Bruley Rosset, Martine ^a,b  

^a UMRS 893   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; PRION PROTEIN; ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PEPTIDE; VAXSYN HIV 1 (GP160) VACCINE; VAXSYN HIV-1 (GP160) VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; C57BL 6 MOUSE; CD4+ CD25+ T LYMPHOCYTE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCRAPIE; T LYMPHOCYTE; ANIMAL; C57BL MOUSE; CLASSIFICATION; DISEASE COURSE; FEMALE; IMMUNOLOGY; PATHOGENICITY; PATHOLOGY; PRION; SECRETION; SURVIVAL RATE;

AIDS VACCINES; ANIMALS; ANTIBODIES; DISEASE PROGRESSION; FEMALE; INTERFERON TYPE II; MICE; MICE, INBRED C57BL; PEPTIDES; PRIONS; SCRAPIE; SURVIVAL RATE; T-LYMPHOCYTES;

EID: 47949097564     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.1.768     Document Type: Article

References (47)

1. Prusiner, S. B. 1998. Prions. Proc. Natl. Acad. Sci. USA 95: 13363-13383.
2. Prusiner, S. B., M. R. Scott, S. J. De Armond, and F. E. Cohen. 1998. Prion protein biology. Cell 93: 337-348.
3. Aucouturier, P., and C. Carnaud. 2002. The immune system and prion diseases: a relationship of complicity and blindness. J. Leukocyte Biol. 72: 107-117.
4. Porter, D. D., H. G. Porter, and N. A. Cox: 1973. Failure to demonstrate a humoral immune response to scrapie infection in mice. J. Immunol. 111: 1407-1410.
5. Bendheim, P. E., H. R. Brown, R. D. Rudelli, L. J. Seala, N. L. Goller, G. Y. Wen, R. J. Kascsak, N. R. Cashman, and D. C. Bolton. 1992. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 42: 149-156.
6. Bard, F., C. Cannon, R. Barbour, R. L. Burke, D. Games, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, et al. 2000. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6: 916-919.
7. Janus, C., J. Pearson, J. McLaurin, P. M. Mathews, Y. Jiang, S. D. Schmidt, M. A. Chisti, P. Home, D. Heslin, J. French, et al. 2000. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408: 979-982.
8. Enari, M., E. Flechsig, and C. Weissmann. 2001. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl. Acad. Sci. USA 98: 9295-9299.
9. Peretz, D. R., A. Williamson, K. Kaneko, J. Vergara, E. Leclerc, G. Schmitt-Ulms, I. R. Mehlhom, G. Legname, M. R. Wormald, P. M. Rudd, et al. 2001. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412: 739-743.
10. Beringue, V., D. Vilette, G. Mallison, F. Archer, M. Kaisar, M. Tayebi, G. S. Jackson, A. R. Clarke, H. Laude, J. Collinge, and S. Hawke. 2004. PrPSc binding antibodies are potent inhibitors of prion replication in cell lines. J. Biol. Chem. 279: 39671-39676.
11. Gilch, S., F. Wopfner, H. Renner-Muller, E. Kremmer, C. Bauer, E. Wolf, G. Brem, M. H. Groschup, and H. M. Schatzl. 2003. Polyclonal anti-PrP auto-antibodies induced with dimeric PrP interfere efficiently with PrPSc propagation in prion-infected cells. J. Biol. Chem. 78: 18524-18531.
12. Pankiewicz, J., F. Prelli, M. S. Sy, R. J. Kascsak, R. B. Kascsak, D. S. Spinner, R. I. Carp, H. C. Meeker, M. Sadowski, and T. Wisniewski. 2006. Clearance and prevention of prion infection in cell culture by anti-PrP antibodies. Eur. J. Neu-rosci. 23: 2635-2647.
13. White, A. R., P. Enever, M. Tayebi, R. Mushens, J. Linehan, S. Brandner, D. Anstee, J. Collinge, and S. Hawke. 2003. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422: 80-83.
14. Heppner, F. L., C. Musahl, I. Arrighi, M. A. Klein, T. Rulicke, B. Oesch, R. M. Zinkernagel, U. Kalinke, and A. Aguzzi. 2001. Prevention of scrapie patho-genesis by transgenic expression of anti-prion protein antibodies. Science 294: 178-182.
15. Schwarz, A., O. Kratke, M. Burwinkel, C. Riemer, J. Schultz, P. Henklein, T. Bamme, and M. Baier. 2003. Immunization with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent. Neurosci. Lett. 350: 187-189.
16. Magri, G., M. Clerici, P. Dall'Ara, M. Biasin, M. Cramelli, C. Casalone, M. L. Giannino, R. Longhi, L. Piacentini, S. Delia Bella, et al. 2005. Decrease in pathology and progression of scrapie after immunization with synthetic prion protein peptides in hamsters. Vaccine 23: 2862-2868.
17. Ishibashi, D., H. Yamanaka, N. Yamaguchi, D. Yoshikawa, R. Nakamura, N. Okimura, Y. Yamaguchi, K. Shigematsu, S. Katamine, and S. Sakaguchi. 2007. Immunization with recombinant bovine but not mouse protein delays the onset of disexse in mice inoculated with a mouse-adapted prion. Vaccine 25: 985-992.
18. Nikles, D., P. Bach, K. Boiler, C. A. Merten, F. Montrasio, F. L. Heppner, A. Aguzzi, K. Cichutek, U. Kalinke, and C. J. Buchholz. 2005. Circumventing tolerance to the prion protein (PrP): vaccination with PrPdisplaying retrovirus particles induces humoral immune responses against the native form of cellular PrP. J. Virol. 79: 4033-4042.
19. Handisurya, A., S. Gilch, D. Winter, S. Shafti-Keramat, D. Maurer, H. M. Schatzl, and R. Kirbauer. 2007. Vaccination with prion peptide-dispaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells. FEBS J. 274: 1747-1758.
20. Yamanaka, H., D. Ishibashi, N. Yamaguchi, D. Yoshikawa, R. Nakamura, N. Okimura, T. Arakawa, T. Tsuji, S. Katamine, and S. Sakaguchi. 2006. Enhanced mucosal immunogenicity of prion protein following fusion with B subunit of Escherichia coli heat-labile enterotoxin. Vaccine 24: 2815-2823.
21. Bade, S., M. Baier, T. Boetel, and A. Frey. 2006. Intranasal immunization of Balb/c mice against prion protein attenuates orally acquired transmissible spon-giform encephalopathy. Vaccine 24: 242-253.
22. Goni, F., E. Knudsen, F. Schreiber, H. Scholtzova, J. Pankiewicz, R. Carp, H. C. Meeker, R. Rubenstein, D. R. Brown, M. S. Sy, et al. 2005. Mucosal vaccination delays or prevents prion infection via an oral route. Neuroscience 133:413-421.
23. Gregoire, S., A. S. Bergot, C. Feraudet, C. Carnaud, P. Aucouturier, and M. B. Rosset. 2005. The murine B-cell repertoire is severely selected against endogenous cellular prion protein. J. Immunol. 175: 6443-6449.
24. Isaacs, J. D., R. J. Ingram, J. Collinge, D. M. Altmann, and G. S. Jackson. 2006. The human prion protein residue 129 polymorphism lies within a cluster of epitopes for T cell recognition. J. Neuropathol. Exp. Neurol. 65: 1059-1068.
25. Khalili-Shirazi, A., S. Quaratino, M. Londei, L. Summers, M. Tayebi, A. R. Clarke, S. H. Hawke, G. S. Jackson, and J. Collinge. 2005. Protein conformation significantly influences immune responses to prion protein. J. Immunol. 174: 3256-3263.
26. Souan, L., Y. Tal, Y. Felling, I. R. Cohen, A. Taraboulos, and F. Mor. 2001. Modulation of proteinase-K resistant prion protein by prion peptide immunization. Eur. J. Immunol. 31: 2338-2346.
27. Lewicki, H., A. Tishon, D. Homann, H. Mazarguil, F. Laval, V. C. Asensio, I. L. Campbell, S. DeArmond, B. Coon, C. Teng, et al. 2003. T cells infiltrate the brain in murine and human transmissible spongiform encephalopathies. J. Virol. 77: 3799-3708.
28. + T cell-mediated immunity against prion proteins. Cell Mol. Life Sci. 60: 629-638.
29. Gregoire, S., C. Logre, P. Metharom, E. Loing, J. Chomillier, M. B. Rosset, P. Aucouturier, and C. Carnaud. 2004. Identification of two immunogenic domains of the prion protein-PrP-which activate class-I restricted T cells and elicit antibody responses against the native molecule. J. Leukocyte Biol. 76: 125-124.
30. Rosset, M. B., C. Ballerini, S. Gregoire, P. Metharom, C. Carnaud, and P. Aucouturier. 2004. Breaking immune tolerance to the prion protein (PrP) with PrP peptides plus oligo-CpG in mice. J. Immunol. 172: 5168-5174.
31. Levavasseur, E., P. Metharom, G. Dorban, H. Nakano, T. Kakiuchi, C. Camaud, P. Sanadin, and P. Aucouturier. 2007. Experimental scrapie in "plt" mice: an assessement of the role of dendritic-cell migration in the pathogenesis of prion diseases. J. Gen. Virol. 88: 2353-2360.
32. Aucouturier, P., F. Geissmann, D. Damotte, G. P. Saborio, H. C. Meeker, R. Kascsak, R. Kascsak, R. I. Carp, and T. Wisniewski. 2001. Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie. J. din. Invest. 108: 703-709.
33. Polymenidou, M., F. L. Heppner, E. C. Pellicioli, E. Urich, G. Miele, N. Braun, F. Wopfner, H. M. Schatzl, B. Becher, and A. Aguzzi. 2004. Humoral immune response to native eukariotic prion protein correlates with anti-prion protection. Proc. Natl. Acad. Sci. USA 101: 14670-14677.
34. Feraudet, C., N. Morel, S. Simon, H. Volland, Y. Frobert, C. Creminon, D. Vilette, S. Lehmann, and 3. Grassi. 2005. Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J. Biol. Chem. 280: 11247-11258.
35. Femandez-Borges, N., A. Brun, J. Lindsay, B. Parra, F. Diaz-San Segundo, F. J. Salguero, J. M. Torres, and F. Rodriguez. 2006. DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge. J. Virol. 80: 9970-9976.
36. Kaiser-Schulz, G., A. Heit, L. Quintanilla-Martinez, F. Hammerschmidt, S. Hess, L. Jenncn, H. Rezaei, H. Wagner, and H. M. Schätzl. 2007. Polylactide-cogly-colide microspheres co-encapsulating recombinanl tandem prion protein with CpG-oligonucleotide break self-tolerance to prion protein in wild-type mice and induce CD4 and CD8 T cell responses. J. Immunol. 179: 2797-2807.
37. Kinsbury, D. T., D. A. Smeltzer, C. J. Gibbs, Jr., and D. C. Gajdusek. 1981. Evidence for normal cell-mediated immunity in scrapie-infected mice. Infect. Immun. 32: 1176-1180.
38. Gardiner, A. C., and A. A. Marucci. 1969. Immunological responsivness of scrapie infected mice. J. Comp. Pathol. 79: 233-235.
39. Garfin, D. E., D. P. Stites, L. A. Zitnik, and S. B. Prusiner. 1978. Suppression of polyclonal B cell activation in scrapie-infected C3H/HeJ mice. J. Immunol. 120-1986-1990.
40. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and A. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
41. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol 22: 531-562.
42. Belkaid, Y., and B. T. Rouse. 2005. Natural regulatory T cells in infectious disease. Nat. Immunol. 6: 353-360.
43. Garza, K. M., S. S. Agesborg, E. Baker, and K. S. Tung. 2000. Persistence of physiological self antigen is required foe the regulation of self tolerance. J. Immunol. 164: 3982-3989.
44. Krieg, A. M. 2002. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20: 709-760.
45. Gilch, S., F. Schmitz, Y. Aguib, C. Kehler, S. Bulow, S. Bauer, E. Kremmer, and H. M. Shatlz. 2007. CpG and LPS can interfere negatively with prion clearance in macrophage and microglial cells. FEBS J. 274: 5834-5844.
46. Sethi, S., G. Lipford, H. Wagner, and H. Kretzschmar. 2002. Postexposure prophylaxis against prion disease with a stimulator of innate immunity. Lancet 360: 229-230.
47. Heikenwalder, M., M. Polymenidou, T. Junt, C. Sigurdson, H. Wagner, S. Akira, and A. Aguzzi. 2004. Lymphoid folicule destruction and immuno-suppression after repeated CpG oligodeoxynucleotide administration. Nat. Med. 10: 187-192.